Lista de obras -

A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group

artículo científico publicado en 2020

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

artículo científico publicado en 2006

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects

artículo científico publicado en 2007

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

artículo científico publicado en 2007

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

artículo científico publicado en 2004

Apolipoproteins are new and better risk indicators of myocardial infarction

artículo científico publicado en 2004

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

artículo científico publicado en 2016

Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study

artículo científico publicado en 2011

Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality

artículo científico publicado en 2016

Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study

artículo científico publicado en 2016

Associations between prediagnostic blood glucose levels, diabetes, and glioma.

artículo científico publicado en 2017

Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study

artículo científico publicado en 2012

Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort

artículo científico publicado en 2017

Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study

scientific article published in PLoS ONE

Chronic kidney disease and 10-year risk of cardiovascular death

artículo científico publicado en 2015

Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort

artículo científico publicado en 2017

Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study

artículo científico publicado en 2017

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

artículo científico publicado en 2008

Country of birth-specific and gender differences in prevalence of diabetes in Sweden

artículo científico publicado en 2013

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

artículo científico publicado en 2006

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

artículo científico publicado en 2010

Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes - experience from the AMORIS study

artículo científico publicado en 2018

Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort

artículo científico publicado en 2014

Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

artículo científico publicado en 2012

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study

artículo científico publicado en 2011

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort

artículo científico publicado en 2017

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort

artículo científico publicado en 2018

Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

artículo científico publicado en 2009

High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study

artículo científico publicado en 2010

Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

artículo científico publicado en 2011

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) ⬇️

artículo científico publicado el 19 de agosto de 2010

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

artículo científico publicado en 2013

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival

artículo científico publicado en 2016

Iron metabolism and risk of cancer in the Swedish AMORIS study

artículo científico publicado en 2013

Levels of lipids and apolipoproteins in three cultures

artículo científico publicado en 2009

Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study

artículo científico publicado en 2012

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study

artículo científico publicado en 2012

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

artículo científico publicado en 2010

Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

artículo científico publicado en 2009

Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study

artículo científico

Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study

article

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

artículo científico publicado en 2015

Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

artículo científico publicado en 2015

Prostate cancer risk in the Swedish AMORIS study

artículo científico publicado en 2010

Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation

artículo científico publicado en 2011

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

scientific article published on 06 September 2016

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

artículo científico publicado en 2012

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS.

artículo científico publicado en 2017

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

artículo científico publicado en 2012

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

artículo científico publicado en 2013

Serum glucose and fructosamine in relation to risk of cancer

artículo científico publicado en 2013

Serum inflammatory markers and colorectal cancer risk and survival

artículo científico publicado en 2017

Serum lactate dehydrogenase and survival following cancer diagnosis

artículo científico publicado en 2015

The AMORIS cohort

artículo científico publicado en 2017

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

artículo científico publicado en 2007

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

artículo científico publicado en 2004

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

artículo científico publicado en 2006

The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

artículo científico publicado en 2017

The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

artículo científico publicado en 2011

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum

artículo científico publicado en 2017

Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden

artículo científico publicado en 2015

Lista de obras de

A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects

Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

Apolipoproteins are new and better risk indicators of myocardial infarction

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories

Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study

Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality

Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study

Associations between prediagnostic blood glucose levels, diabetes, and glioma.

Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study

Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort

Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study

Chronic kidney disease and 10-year risk of cardiovascular death

Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort

Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

Country of birth-specific and gender differences in prevalence of diabetes in Sweden

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease

Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes - experience from the AMORIS study

Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort

Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort

Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study

Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) ⬇️

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival

Iron metabolism and risk of cancer in the Swedish AMORIS study

Levels of lipids and apolipoproteins in three cultures

Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Low fructosamine and mortality - A long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study

Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

Prostate cancer risk in the Swedish AMORIS study

Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS.

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

Serum glucose and fructosamine in relation to risk of cancer

Serum inflammatory markers and colorectal cancer risk and survival

Serum lactate dehydrogenase and survival following cancer diagnosis

The AMORIS cohort

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum

Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden